Search

everythinglearnresearchcommunity

for

Search:↓

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Entospletinib effectively prevents eye and skin GVHD in mice.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Mice with enhanced regeneration abilities may help develop new regenerative medicine therapies.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Immune cells affect hair growth and could lead to new hair loss treatments.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

5alpha-reductase 2 is crucial for proper male brain development and sexual differentiation.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Nagashima-type palmoplantar keratosis in Asians is caused by a SERPINB7 gene mutation.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Targeting EGFR may help reduce hair loss from chemotherapy.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Neurosteroids help balance brain signals when certain inhibitions are reduced.

Neonatal neurosteroid levels affect adult brain function and behavior.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.